SUMMARY
Background Dementia is defined by cognitive decline that affects functional status. Longitudinal ageing surveys often lack a clinical diagnosis of dementia though measure cognitive and function over time. We used unsupervised machine learning and longitudinal data to identify transition to probable dementia.
Methods Multiple Factor Analysis was applied to longitudinal function and cognitive data of 15,278 baseline participants (aged 50 years and more) from the Survey of Health, Ageing, and Retirement in Europe (SHARE) (waves 1, 2 and 4–7, between 2004 and 2017). Hierarchical Clustering on Principal Components discriminated three clusters at each wave. We estimated probable or “Likely Dementia” prevalence by sex and age, and assessed whether dementia risk factors increased the risk of being assigned probable dementia status using multistate models. Next, we compared the “Likely Dementia” cluster with self-reported dementia status and replicated our findings in the English Longitudinal Study of Ageing (ELSA) cohort (waves 1–9, between 2002 and 2019, 7,840 participants at baseline).
Findings Our algorithm identified a higher number of probable dementia cases compared with self-reported cases and showed good discriminative power across all waves (AUC ranged from 0.754 [0.722–0.787] to 0.830 [0.800–0.861]). “Likely Dementia” status was more prevalent in older people, displayed a 2:1 female/male ratio and was associated with nine factors that increased risk of transition to dementia: low education, hearing loss, hypertension, drinking, smoking, depression, social isolation, physical inactivity, diabetes, and obesity. Results were replicated in ELSA cohort with good accuracy.
Interpretation Machine learning clustering can be used to study dementia determinants and outcomes in longitudinal population ageing surveys in which dementia clinical diagnosis is lacking.
Funding French Institute for Public Health Research (IReSP), French National Institute for Health and Medical Research (Inserm), NeurATRIS Grant (ANR-11-INBS-0011), and Front-Cog University Research School (ANR-17-EUR-0017).
Competing Interest Statement
EB is an advisory board member of SafelyYou. EB has vested stock options in SafelyYou stock. KF is a participant on a data safety monitoring board Eli Lilly and NIH-sponsored trials. KF is a board member of Alector. ACBL has received academic grants from the French National Research Agency (ANR-17-EURE-0017) and NeurATRIS (ANR-11-INBS-0011). ACBL has received fees for consultancy work from Roche. All other authors declare no competing interests.
Funding Statement
French Institute for Public Health Research (IReSP), French National Institute for Health and Medical Research (Inserm), NeurATRIS Grant (ANR-11-INBS-0011), and Front-Cog University Research School (ANR-17-EUR-0017).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All the data we used are publicly available. We used the harmonised versions of SHARE and ELSA provided by the Gateway to Global Aging Data (https://g2aging.org/).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
ELSA raw data can be downloaded via the UK Data Service (https://ukdataservice.ac.uk/find-data/). SHARE raw data can be accessed on their website (http://www.share-project.org/data-access.html).
